论文部分内容阅读
目的:观察奥美拉唑联合雷贝拉唑治疗消化性溃疡疗效。方法:回顾性分析我院2013年6月-2015年6月收治的90例消化性溃疡患者的临床资料,根据不同治疗方案分为两组(各45例),对照组予以奥美拉唑治疗,研究组联合雷贝拉唑治疗,观察并比较两组临床疗效及不良反应情况。结果:研究组总有效率比对照组明显升高(95.55%vs 73.33%,P<0.05);研究组不良反应总发生率比对照组略低(6.67%vs 11.11%,P>0.05)。结论 :奥美拉唑联合雷贝拉唑治疗消化性溃疡疗效显著,且安全性高,值得临床推广及应用。
Objective: To observe the curative effect of omeprazole and rabeprazole on peptic ulcer. Methods: The clinical data of 90 patients with peptic ulcer admitted from June 2013 to June 2015 in our hospital were retrospectively analyzed. According to different treatment plans, the patients were divided into two groups (45 cases each), and the control group was treated with omeprazole , The study group combined with rabeprazole treatment, observed and compared the clinical efficacy and adverse reactions in the two groups. Results: The total effective rate in the study group was significantly higher than that in the control group (95.55% vs 73.33%, P <0.05). The overall incidence of adverse reactions in the study group was slightly lower than that in the control group (6.67% vs 11.11%, P> 0.05). Conclusion: Omeprazole combined with Rabeprazole is effective in treating peptic ulcer with high safety. It is worthy of clinical application and promotion.